Disclosures for "Eye Movement Abnormalities Across the Spinocerebellar Ataxias: A Large Cohort Analysis"
-
Dr. Shimanovich has nothing to disclose.
-
Dr. Taha has nothing to disclose.
-
Prof. Wang has nothing to disclose.
-
Mr. Gama has nothing to disclose.
-
Dr. Ranum has stock in RanTran. An immediate family member of Dr. Ranum has stock in RanTran. The institution of Dr. Ranum has received research support from Latus Bio. Dr. Ranum has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.